moxifloxacin has been researched along with etidronate in 3 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (etidronate) | Trials (etidronate) | Recent Studies (post-2010) (etidronate) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 2,819 | 510 | 432 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, C; Cherian, P; Ebetino, FH; Hu, E; Junka, AF; McKenna, CE; Neighbors, J; Pawlak, J; Roshandel, S; Russell, RGG; Sedghizadeh, PP; Sodagar, E; Sun, S; Tjokro, N | 1 |
1 review(s) available for moxifloxacin and etidronate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for moxifloxacin and etidronate
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Diphosphonates; Durapatite; Electric Impedance; Etidronic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus | 2023 |